NAV3 is a genetic determinant of myocardial recovery in dilated cardiomyopathy and attenuates cardiac fibrosis

Back

ESC Professional Premium Access

NAV3 is a genetic determinant of myocardial recovery in dilated cardiomyopathy and attenuates cardiac fibrosis

Session: Pathophysiological mechanisms in cardiomyopathies and hypertrophic remodeling

Topic: Cardiomyopathies

Speaker: Doctor N. Pereira (Rochester, US)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Naveen Pereira

Mayo Clinic, Rochester (United States of America)

0 follower

4 more presentations in this session

Increased Tenascin-C expression contributes to cardiac dysfunction and fibrosis in Duchenne muscular dystrophy

Speaker: Associate Professor A. Kiss (Vienna, AT)

Desmoglein 2 mutant mice reproduce arrhythmogenic right ventricular cardiomyopathy patients' phenotype

Speaker: Doctor S. Ohno (Suita, JP)

The role of the atrium in the development of the Takotsubo Syndrome - investigation of a patient-specific atrial stem cell model

Speaker: Doctor K. Streckfuss-Boemeke (Wuerzburg, DE)

Dysferlin facilitates the de novo biogenesis of tubular membranes in hypertrophic remodelling

Speaker: Ms N. Paulke (Goettingen, DE)

Access the full session

Pathophysiological mechanisms in cardiomyopathies and hypertrophic remodeling

Speakers: Doctor N. Pereira, Associate Professor A. Kiss, Doctor S. Ohno, Doctor K. Streckfuss-Boemeke, Ms N. Paulke

Access

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources